| Year |
Citation |
Score |
| 2024 |
Thompson EM, Kang KD, Stevenson K, Zhang H, Gromeier M, Ashley D, Brown M, Friedman GK. Elucidating cellular response to treatment with viral immunotherapies in pediatric high-grade glioma and medulloblastoma. Translational Oncology. 40: 101875. PMID 38183802 DOI: 10.1016/j.tranon.2024.101875 |
0.304 |
|
| 2022 |
Dobrikov MI, Dobrikova EY, McKay ZP, Kastan JP, Brown MC, Gromeier M. PKR Binds Enterovirus IRESs, Displaces Host Translation Factors, and Impairs Viral Translation to Enable Innate Antiviral Signaling. Mbio. e0085422. PMID 35652592 DOI: 10.1128/mbio.00854-22 |
0.359 |
|
| 2021 |
Kastan JP, Tremblay MW, Brown MC, Trimarco JD, Dobrikova EY, Dobrikov MI, Gromeier M. Enterovirus 2A Cleavage of the YTHDF mA Readers Implicates YTHDF3 as a Mediator of Type I Interferon-Driven JAK/STAT Signaling. Mbio. 12. PMID 33849973 DOI: 10.1128/mBio.00116-21 |
0.337 |
|
| 2020 |
Mosaheb MM, Brown MC, Dobrikova EY, Dobrikov MI, Gromeier M. Harnessing virus tropism for dendritic cells for vaccine design. Current Opinion in Virology. 44: 73-80. PMID 32771959 DOI: 10.1016/J.Coviro.2020.07.012 |
0.333 |
|
| 2020 |
Kastan JP, Dobrikova EY, Bryant JD, Gromeier M. CReP mediates selective translation initiation at the endoplasmic reticulum. Science Advances. 6: eaba0745. PMID 32537501 DOI: 10.1126/Sciadv.Aba0745 |
0.403 |
|
| 2020 |
Mosaheb MM, Dobrikova EY, Brown MC, Yang Y, Cable J, Okada H, Nair SK, Bigner DD, Ashley DM, Gromeier M. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nature Communications. 11: 524. PMID 31988324 DOI: 10.1038/S41467-019-13939-Z |
0.354 |
|
| 2019 |
Chandramohan V, Bao X, Yu X, Parker S, McDowall C, Yu YR, Healy P, Desjardins A, Gunn MD, Gromeier M, Nair SK, Pastan IH, Bigner DD. Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations. Journal For Immunotherapy of Cancer. 7: 142. PMID 31142380 DOI: 10.1186/S40425-019-0614-0 |
0.354 |
|
| 2019 |
Yu X, Dobrikov M, Keir ST, Gromeier M, Pastan IH, Reisfeld R, Bigner DD, Chandramohan V. Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors. Plos One. 14: e0210608. PMID 30625226 DOI: 10.1371/Journal.Pone.0210608 |
0.348 |
|
| 2019 |
Bowie M, Hariharan S, Hostettler J, Roso K, He Y, Pirozzi C, Roskoski M, Keir S, Brown M, Zhang G, Gromeier M, Yan H, Ashley D. IMMU-34. ATRX MUTATIONS PREDICT RESPONSE TO INNATE BASED THERAPY IN GLIOMA Neuro-Oncology. 21: vi126-vi126. DOI: 10.1093/Neuonc/Noz175.526 |
0.386 |
|
| 2019 |
Gromeier M, Mosaheb M, Dobrikova E, Brown M, Bigner D, Ashley D. EXTH-51. GENETICALLY STABLE POLIOVIRUS VECTOR PLATFORM FOR DIPG IMMUNOTHERAPY Neuro-Oncology. 21: vi93-vi93. DOI: 10.1093/Neuonc/Noz175.382 |
0.373 |
|
| 2019 |
Gromeier M, Brown M, Beuabier N, Yan H, He Y, Zhang G, Desjardins A, Herndon J, Bolognesi D, Friedman A, Friedman H, McSherry F, Lin X, Wei Z, Nair S, et al. ATIM-27. TUMOR MUTATIONAL BURDEN PREDICTS RESPONSE TO ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN MALIGNANT GLIOMA PATIENTS: ASSESSMENT OF TRANSCRIPTIONAL AND IMMUNOLOGICAL CORRELATES Neuro-Oncology. 21: vi7-vi7. DOI: 10.1093/Neuonc/Noz175.026 |
0.374 |
|
| 2018 |
Dobrikov MI, Dobrikova EY, Gromeier M. Ribosomal RACK1:PKCβII modulates intramolecular interactions between unstructured regions of eIF4G that control eIF4E and eIF3 binding. Molecular and Cellular Biology. PMID 30012864 DOI: 10.1128/Mcb.00306-18 |
0.378 |
|
| 2018 |
Dobrikov MI, Dobrikova EY, Gromeier M. Ribosomal RACK1:PKCβII phosphorylates eIF4G1(S1093) to modulate cap-dependent and -independent translation initiation. Molecular and Cellular Biology. PMID 30012863 DOI: 10.1128/Mcb.00304-18 |
0.426 |
|
| 2018 |
Dobrikov MI, Dobrikova EY, Gromeier M. Ribosomal RACK1:PKCβII phosphorylates eIF4G1(S1093) to modulate cap-dependent and -independent translation initiation. Molecular and Cellular Biology. PMID 30012863 DOI: 10.1128/MCB.00304-18 |
0.314 |
|
| 2018 |
Walton RW, Brown MC, Sacco MT, Gromeier M. Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells. Journal of Virology. PMID 29997212 DOI: 10.1128/Jvi.00879-18 |
0.423 |
|
| 2018 |
Thompson EM, Brown M, Dobrikova E, Ramaswamy V, Taylor MD, McLendon R, Sanks J, Chandramohan V, Bigner D, Gromeier M. Poliovirus Receptor (CD155) Expression in Pediatric Brain Tumors Mediates Oncolysis of Medulloblastoma and Pleomorphic Xanthoastrocytoma. Journal of Neuropathology and Experimental Neurology. PMID 29878245 DOI: 10.1093/Jnen/Nly045 |
0.379 |
|
| 2018 |
Bryant JD, Brown MC, Dobrikov MI, Dobrikova EY, Gemberling SL, Zhang Q, Gromeier M. Regulation of HIF-1α during Hypoxia by DAP5-Induced Translation of PHD2. Molecular and Cellular Biology. PMID 29530922 DOI: 10.1128/Mcb.00647-17 |
0.352 |
|
| 2018 |
Gromeier M, Nair SK. Recombinant Poliovirus for Cancer Immunotherapy. Annual Review of Medicine. 69: 289-299. PMID 29414253 DOI: 10.1146/Annurev-Med-050715-104655 |
0.383 |
|
| 2018 |
Evans MK, Brown MC, Geradts J, Bao X, Robinson TJ, Jolly MK, Vermeulen P, Palmer GM, Gromeier M, Levine H, Morse MA, Van Laere S, Devi GR. XIAP regulation by MNK links MAPK and NFκB signaling to determine an aggressive breast cancer phenotype. Cancer Research. PMID 29351901 DOI: 10.1158/0008-5472.Can-17-1667 |
0.395 |
|
| 2018 |
Brown MC, Holl EK, Boczkowski D, Dobrikova E, Mosaheb M, Chandramohan V, Bigner DD, Gromeier M, Nair SK. Abstract A79: Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of antigen-presenting cells and tumor antigen-specific CTLs Cancer Immunology Research. 6. DOI: 10.1158/2326-6074.Tumimm17-A79 |
0.363 |
|
| 2018 |
Landa K, Holl E, Brown M, Herndon J, Grimm L, Force J, Bigner D, Hwang S, Gromeier M, Nair S. Abstract LB-302: Oncolytic poliovirus-mediated inflammation and immunity in breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-302 |
0.33 |
|
| 2018 |
Thompson E, Brown M, Dobrikova E, Ramaswamy V, Taylor M, McLendon R, Chandramohan V, Bigner D, Gromeier M. PDTM-46. POLIOVIRUS RECEPTOR (CD155) EXPRESSION IN PEDIATRIC BRAIN TUMORS MEDIATES ONCOLYSIS OF MEDULLOBLASTOMA AND PLEOMORPHIC XANTHOASTROCYTOMA Neuro-Oncology. 20: vi213-vi213. DOI: 10.1093/Neuonc/Noy148.885 |
0.307 |
|
| 2017 |
Brown MC, Holl EK, Boczkowski D, Dobrikova E, Mosaheb M, Chandramohan V, Bigner DD, Gromeier M, Nair SK. Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs. Science Translational Medicine. 9. PMID 28931654 DOI: 10.1126/Scitranslmed.Aan4220 |
0.358 |
|
| 2017 |
Chandramohan V, Bryant JD, Piao H, Keir ST, Lipp ES, Lefaivre M, Perkinson K, Bigner DD, Gromeier M, McLendon RE. Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas. Archives of Pathology & Laboratory Medicine. PMID 28829151 DOI: 10.5858/Arpa.2016-0580-Oa |
0.318 |
|
| 2017 |
Brown MC, Gromeier M. MNK inversely regulates TELO2 vs. DEPTOR to control mTORC1 signaling. Molecular & Cellular Oncology. 4: e1306010. PMID 28616583 DOI: 10.1080/23723556.2017.1306010 |
0.379 |
|
| 2017 |
Brown MC, Gromeier M. MNK Controls mTORC1:Substrate Association through Regulation of TELO2 Binding with mTORC1. Cell Reports. 18: 1444-1457. PMID 28178522 DOI: 10.1016/J.Celrep.2017.01.023 |
0.398 |
|
| 2016 |
Holl EK, Brown MC, Boczkowski D, McNamara MA, George DJ, Bigner DD, Gromeier M, Nair SK. Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models. Oncotarget. PMID 27806313 DOI: 10.18632/Oncotarget.12975 |
0.385 |
|
| 2016 |
Desjardins A, Sampson JH, Peters KB, Vlahovic G, Randazzo D, Threatt S, Herndon JE, Boulton S, Lally-Goss D, McSherry F, Lipp ES, Friedman AH, Friedman HS, Bigner DD, Gromeier M. Patient survival on the dose escalation phase of the Oncolytic Polio/Rhinovirus Recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG) clinical trial compared to historical controls. Journal of Clinical Oncology. 34: 2061-2061. DOI: 10.1200/Jco.2016.34.15_Suppl.2061 |
0.321 |
|
| 2016 |
Brown MC, Holl EK, Boczkowski D, Bigner DD, Gromeier M, Nair SK. Abstract A157: Oncolytic poliovirus mediated immune events Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-A157 |
0.401 |
|
| 2016 |
Mosaheb MM, Dobrikova E, Brown MC, Pirozzi C, Chandramohan V, Holl E, Nair S, Gromeier M. Abstract A032: Using oncolytic polio expressing tumor as a cancer vaccine Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-A032 |
0.393 |
|
| 2015 |
Brown MC, Gromeier M. Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus. Current Opinion in Virology. 13: 81-85. PMID 26083317 DOI: 10.1016/J.Coviro.2015.05.007 |
0.382 |
|
| 2015 |
Brown MC, Holl E, Boczkowski D, Walton R, Bigner DD, Gromeier M, Nair SK. Oncolytic poliovirus directs tumor antigen presentation and T cell activation in vitro Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P332 |
0.362 |
|
| 2014 |
Brown MC, Bryant JD, Dobrikova EY, Shveygert M, Bradrick SS, Chandramohan V, Bigner DD, Gromeier M. Induction of viral, 7-methyl-guanosine cap-independent translation and oncolysis by mitogen-activated protein kinase-interacting kinase-mediated effects on the serine/arginine-rich protein kinase. Journal of Virology. 88: 13135-48. PMID 25187541 DOI: 10.1128/Jvi.01883-14 |
0.81 |
|
| 2014 |
Brown MC, Dobrikov MI, Gromeier M. Mitogen-activated protein kinase-interacting kinase regulates mTOR/AKT signaling and controls the serine/arginine-rich protein kinase-responsive type 1 internal ribosome entry site-mediated translation and viral oncolysis. Journal of Virology. 88: 13149-60. PMID 25187540 DOI: 10.1128/Jvi.01884-14 |
0.428 |
|
| 2014 |
Brown MC, Dobrikova EY, Dobrikov MI, Walton RW, Gemberling SL, Nair SK, Desjardins A, Sampson JH, Friedman HS, Friedman AH, Tyler DS, Bigner DD, Gromeier M. Oncolytic polio virotherapy of cancer. Cancer. 120: 3277-86. PMID 24939611 DOI: 10.1002/Cncr.28862 |
0.394 |
|
| 2014 |
Dobrikov MI, Shveygert M, Brown MC, Gromeier M. Mitotic phosphorylation of eukaryotic initiation factor 4G1 (eIF4G1) at Ser1232 by Cdk1:cyclin B inhibits eIF4A helicase complex binding with RNA. Molecular and Cellular Biology. 34: 439-51. PMID 24248602 DOI: 10.1128/Mcb.01046-13 |
0.787 |
|
| 2014 |
Gromeier M, Dobrikova E, Dobrikov M, Brown M, Bryant J, Threatt S, Boulton S, Carter K, Herndon J, Desjardins A, Friedman H, Sampson J, Friedman A, Bigner D. ONCOLYTIC POLIOVIRUS IMMUNOTHERAPY OF GLIOBLASTOMA Neuro-Oncology. 16: iii41-iii41. DOI: 10.1093/Neuonc/Nou208.69 |
0.498 |
|
| 2013 |
Dobrikov MI, Dobrikova EY, Gromeier M. Dynamic regulation of the translation initiation helicase complex by mitogenic signal transduction to eukaryotic translation initiation factor 4G. Molecular and Cellular Biology. 33: 937-46. PMID 23263986 DOI: 10.1128/Mcb.01441-12 |
0.401 |
|
| 2013 |
Lawson SK, Dobrikova EY, Shveygert M, Gromeier M. p38α mitogen-activated protein kinase depletion and repression of signal transduction to translation machinery by miR-124 and -128 in neurons. Molecular and Cellular Biology. 33: 127-35. PMID 23109423 DOI: 10.1128/Mcb.00695-12 |
0.78 |
|
| 2013 |
Sampson JH, Desjardins A, Peters KB, Ranjan T, Vlahovic G, Lally-Goss D, Threatt S, Herndon J, Friedman AH, Friedman H, Bigner D, Gromeier M. 107 Dose-Finding and Safety Study of an Oncolytic Polio/Rhinovirus Recombinant Against Recurrent Glioblastoma Neurosurgery. 60: 155. DOI: 10.1200/Jco.2013.31.15_Suppl.2094 |
0.332 |
|
| 2012 |
Dobrikova EY, Goetz C, Walters RW, Lawson SK, Peggins JO, Muszynski K, Ruppel S, Poole K, Giardina SL, Vela EM, Estep JE, Gromeier M. Attenuation of neurovirulence, biodistribution, and shedding of a poliovirus:rhinovirus chimera after intrathalamic inoculation in Macaca fascicularis. Journal of Virology. 86: 2750-9. PMID 22171271 DOI: 10.1128/Jvi.06427-11 |
0.638 |
|
| 2011 |
Goetz C, Dobrikova E, Shveygert M, Dobrikov M, Gromeier M. Oncolytic poliovirus against malignant glioma. Future Virology. 6: 1045-1058. PMID 21984883 DOI: 10.2217/Fvl.11.76 |
0.789 |
|
| 2011 |
Dobrikov M, Dobrikova E, Shveygert M, Gromeier M. Phosphorylation of eukaryotic translation initiation factor 4G1 (eIF4G1) by protein kinase C{alpha} regulates eIF4G1 binding to Mnk1. Molecular and Cellular Biology. 31: 2947-59. PMID 21576361 DOI: 10.1128/Mcb.05589-11 |
0.786 |
|
| 2011 |
Wang ES, Dobrikova E, Goetz C, Dufresne AT, Gromeier M. Adaptation of an ICAM-1-tropic enterovirus to the mouse respiratory tract. Journal of Virology. 85: 5606-17. PMID 21450825 DOI: 10.1128/Jvi.01502-10 |
0.57 |
|
| 2010 |
Shveygert M, Kaiser C, Bradrick SS, Gromeier M. Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-activated protein kinase occurs through modulation of Mnk1-eIF4G interaction. Molecular and Cellular Biology. 30: 5160-7. PMID 20823271 DOI: 10.1128/Mcb.00448-10 |
0.768 |
|
| 2010 |
Neplioueva V, Dobrikova EY, Mukherjee N, Keene JD, Gromeier M. Tissue type-specific expression of the dsRNA-binding protein 76 and genome-wide elucidation of its target mRNAs. Plos One. 5: e11710. PMID 20668518 DOI: 10.1371/Journal.Pone.0011710 |
0.432 |
|
| 2010 |
Goetz C, Everson RG, Zhang LC, Gromeier M. MAPK signal-integrating kinase controls cap-independent translation and cell type-specific cytotoxicity of an oncolytic poliovirus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1937-46. PMID 20648000 DOI: 10.1038/Mt.2010.145 |
0.671 |
|
| 2010 |
Goetz C, Gromeier M. Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme. Cytokine & Growth Factor Reviews. 21: 197-203. PMID 20299272 DOI: 10.1016/J.Cytogfr.2010.02.005 |
0.628 |
|
| 2010 |
Dobrikova E, Shveygert M, Walters R, Gromeier M. Herpes simplex virus proteins ICP27 and UL47 associate with polyadenylate-binding protein and control its subcellular distribution. Journal of Virology. 84: 270-9. PMID 19864386 DOI: 10.1128/Jvi.01740-09 |
0.805 |
|
| 2009 |
Bradrick SS, Gromeier M. Identification of gemin5 as a novel 7-methylguanosine cap-binding protein. Plos One. 4: e7030. PMID 19750007 DOI: 10.1371/Journal.Pone.0007030 |
0.344 |
|
| 2009 |
Yang X, Chen E, Jiang H, Muszynski K, Harris RD, Giardina SL, Gromeier M, Mitra G, Soman G. Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay. Journal of Virological Methods. 155: 44-54. PMID 18951922 DOI: 10.1016/J.Jviromet.2008.09.020 |
0.397 |
|
| 2008 |
Dobrikova EY, Broadt T, Poiley-Nelson J, Yang X, Soman G, Giardina S, Harris R, Gromeier M. Recombinant oncolytic poliovirus eliminates glioma in vivo without genetic adaptation to a pathogenic phenotype. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1865-72. PMID 18766173 DOI: 10.1038/Mt.2008.184 |
0.361 |
|
| 2008 |
Kaiser C, Dobrikova EY, Bradrick SS, Shveygert M, Herbert JT, Gromeier M. Activation of cap-independent translation by variant eukaryotic initiation factor 4G in vivo. Rna (New York, N.Y.). 14: 2170-82. PMID 18755839 DOI: 10.1261/Rna.1171808 |
0.773 |
|
| 2008 |
Everson RG, Graner MW, Gromeier M, Vredenburgh JJ, Desjardins A, Reardon DA, Friedman HS, Friedman AH, Bigner DD, Sampson JH. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma. Expert Review of Anticancer Therapy. 8: 717-32. PMID 18471045 DOI: 10.1586/14737140.8.5.717 |
0.326 |
|
| 2008 |
Cello J, Toyoda H, Dejesus N, Dobrikova EY, Gromeier M, Wimmer E. Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses. Journal of Medical Virology. 80: 352-9. PMID 18098139 DOI: 10.1002/Jmv.21063 |
0.34 |
|
| 2007 |
Bradrick SS, Dobrikova EY, Kaiser C, Shveygert M, Gromeier M. Poly(A)-binding protein is differentially required for translation mediated by viral internal ribosome entry sites. Rna (New York, N.Y.). 13: 1582-93. PMID 17652408 DOI: 10.1261/Rna.556107 |
0.778 |
|
| 2007 |
Florez de Sessions P, Dobrikova E, Gromeier M. Genetic adaptation to untranslated region-mediated enterovirus growth deficits by mutations in the nonstructural proteins 3AB and 3CD. Journal of Virology. 81: 8396-405. PMID 17537861 DOI: 10.1128/Jvi.00321-07 |
0.473 |
|
| 2007 |
Campbell SA, Mulvey M, Mohr I, Gromeier M. Attenuation of herpes simplex virus neurovirulence with picornavirus cis-acting genetic elements. Journal of Virology. 81: 791-9. PMID 17079296 DOI: 10.1128/Jvi.00714-06 |
0.49 |
|
| 2006 |
Merrill MK, Gromeier M. The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site. Journal of Virology. 80: 6936-42. PMID 16809299 DOI: 10.1128/Jvi.00243-06 |
0.786 |
|
| 2006 |
Dobrikova EY, Grisham RN, Kaiser C, Lin J, Gromeier M. Competitive translation efficiency at the picornavirus type 1 internal ribosome entry site facilitated by viral cis and trans factors. Journal of Virology. 80: 3310-21. PMID 16537598 DOI: 10.1128/Jvi.80.7.3310-3321.2006 |
0.663 |
|
| 2006 |
Merrill MK, Dobrikova EY, Gromeier M. Cell-type-specific repression of internal ribosome entry site activity by double-stranded RNA-binding protein 76. Journal of Virology. 80: 3147-56. PMID 16537583 DOI: 10.1128/Jvi.80.7.3147-3156.2006 |
0.791 |
|
| 2006 |
Bradrick SS, Walters RW, Gromeier M. The hepatitis C virus 3'-untranslated region or a poly(A) tract promote efficient translation subsequent to the initiation phase. Nucleic Acids Research. 34: 1293-303. PMID 16510853 DOI: 10.1093/Nar/Gkl019 |
0.35 |
|
| 2006 |
Merrill MK, Selznick LA, Gromeier M. Oncolytic viruses for the treatment of malignant glioma Expert Opinion On Therapeutic Patents. 16: 363-371. DOI: 10.1517/13543776.16.3.363 |
0.758 |
|
| 2005 |
Campbell SA, Lin J, Dobrikova EY, Gromeier M. Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells. Journal of Virology. 79: 6281-90. PMID 15858012 DOI: 10.1128/Jvi.79.10.6281-6290.2005 |
0.348 |
|
| 2005 |
Florez PM, Sessions OM, Wagner EJ, Gromeier M, Garcia-Blanco MA. The polypyrimidine tract binding protein is required for efficient picornavirus gene expression and propagation. Journal of Virology. 79: 6172-9. PMID 15858002 DOI: 10.1128/Jvi.79.10.6172-6179.2005 |
0.441 |
|
| 2005 |
Campbell SA, Gromeier M. Oncolytic viruses for cancer therapy II. Cell-internal factors for conditional growth in neoplastic cells. Onkologie. 28: 209-15. PMID 15840970 DOI: 10.1159/000084010 |
0.431 |
|
| 2005 |
Campbell SA, Gromeier M. Oncolytic viruses for cancer therapy I. Cell-external factors: virus entry and receptor interaction. Onkologie. 28: 144-9. PMID 15772465 DOI: 10.1159/000083659 |
0.431 |
|
| 2005 |
Moore SA, Merrill MK, Gromeier M. Treatment of CNS malignancies with a recombinant oncolytic poliovirus Drug Design Reviews Online. 2: 233-241. DOI: 10.2174/1567269053828774 |
0.788 |
|
| 2004 |
Dufresne AT, Gromeier M. A nonpolio enterovirus with respiratory tropism causes poliomyelitis in intercellular adhesion molecule 1 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 101: 13636-41. PMID 15353596 DOI: 10.1073/Pnas.0403998101 |
0.304 |
|
| 2004 |
Merrill MK, Bernhardt G, Sampson JH, Wikstrand CJ, Bigner DD, Gromeier M. Poliovirus receptor CD155-targeted oncolysis of glioma. Neuro-Oncology. 6: 208-17. PMID 15279713 DOI: 10.1215/S1152851703000577 |
0.76 |
|
| 2003 |
Scheuner D, Gromeier M, Davies MV, Dorner AJ, Song B, Patel RV, Wimmer EJ, McLendon RE, Kaufman RJ. The double-stranded RNA-activated protein kinase mediates viral-induced encephalitis. Virology. 317: 263-74. PMID 14698665 DOI: 10.1016/J.Virol.2003.08.010 |
0.367 |
|
| 2003 |
Dobrikova E, Florez P, Bradrick S, Gromeier M. Activity of a type 1 picornavirus internal ribosomal entry site is determined by sequences within the 3' nontranslated region. Proceedings of the National Academy of Sciences of the United States of America. 100: 15125-30. PMID 14645707 DOI: 10.1073/Pnas.2436464100 |
0.455 |
|
| 2003 |
Gromeier M. Oncolytic Viruses for Cancer Therapy American Journal of Cancer. 2: 313-323. DOI: 10.2165/00024669-200302050-00002 |
0.407 |
|
| 2002 |
Fecci PE, Gromeier M, Sampson JH. Viruses in the treatment of brain tumors Neuroimaging Clinics of North America. 12: 553-570. PMID 12687911 DOI: 10.1016/S1052-5149(02)00028-X |
0.363 |
|
| 2002 |
Solecki DJ, Gromeier M, Mueller S, Bernhardt G, Wimmer E. Expression of the human poliovirus receptor/CD155 gene is activated by sonic hedgehog. The Journal of Biological Chemistry. 277: 25697-702. PMID 11983699 DOI: 10.1074/Jbc.M201378200 |
0.324 |
|
| 2000 |
Gromeier M, Solecki D, Patel DD, Wimmer E. Expression of the human poliovirus receptor/CD155 gene during development of the central nervous system: implications for the pathogenesis of poliomyelitis. Virology. 273: 248-57. PMID 10915595 DOI: 10.1006/Viro.2000.0418 |
0.3 |
|
| 2000 |
Gromeier M, Lachmann S, Rosenfeld MR, Gutin PH, Wimmer E. Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proceedings of the National Academy of Sciences of the United States of America. 97: 6803-8. PMID 10841575 DOI: 10.1073/Pnas.97.12.6803 |
0.446 |
|
| 1999 |
Gromeier M, Bossert B, Arita M, Nomoto A, Wimmer E. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. Journal of Virology. 73: 958-64. PMID 9882296 DOI: 10.1128/Jvi.73.2.958-964.1999 |
0.402 |
|
| 1998 |
Solecki D, Gromeier M, Harber J, Bernhardt G, Wimmer E. Poliovirus and its cellular receptor: a molecular genetic dissection of a virus/receptor affinity interaction. Journal of Molecular Recognition : Jmr. 11: 2-9. PMID 10076797 DOI: 10.1002/(Sici)1099-1352(199812)11:1/6<2::Aid-Jmr380>3.0.Co;2-D |
0.366 |
|
| 1998 |
Das S, Ott M, Yamane A, Tsai W, Gromeier M, Lahser F, Gupta S, Dasgupta A. A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element Journal of Virology. 72: 5638-5647. PMID 9621022 DOI: 10.1128/Jvi.72.7.5638-5647.1998 |
0.338 |
|
| 1997 |
Duggal R, Cuconati A, Gromeier M, Wimmer E. Genetic recombination of poliovirus in a cell-free system. Proceedings of the National Academy of Sciences of the United States of America. 94: 13786-91. PMID 9391105 DOI: 10.1073/Pnas.94.25.13786 |
0.351 |
|
| 1995 |
Gromeier M, Lu HH, Bernhardt G, Harber JJ, Bibb JA, Wimmer E. The human poliovirus receptor. Receptor-virus interaction and parameters of disease specificity. Annals of the New York Academy of Sciences. 753: 19-36. PMID 7611627 DOI: 10.1111/J.1749-6632.1995.Tb27528.X |
0.356 |
|
| 1994 |
Wimmer E, Harber JJ, Bibb JA, Gromeier M, Lu H, Bernhardt G. 7 Poliovirus Receptors Cold Spring Harbor Monograph Archive. 28: 101-127. DOI: 10.1101/087969429.28.101 |
0.351 |
|
| 1990 |
Gromeier M, Wetz K. Kinetics of poliovirus uncoating in HeLa Cells in a nonacidic environment Journal of Virology. 64: 3590-3597. PMID 2164587 DOI: 10.1128/Jvi.64.8.3590-3597.1990 |
0.341 |
|
| Show low-probability matches. |